Idiopathic nodular glomerulosclerosis: a clinicopathologic study of 15 cases

Human Pathology

Volumn 39, Issue 12, 2008, Pages 1771-1776

  Li, Wei ^a   Verani, Regina R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Hypertension; Idiopathic nodular glomerulosclerosis; Obesity; Smoking

Indexed keywords

CREATININE;

ADULT; AGED; AGING; ARTERIOLOSCLEROSIS; ARTICLE; BODY MASS; CAUCASIAN; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IDIOPATHIC NODULAR GLOMERULOSCLEROSIS; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; NEPHROTIC SYNDROME; OBESITY; PATHOGENESIS; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGED; ARTERIOLOSCLEROSIS; ARTERIOSCLEROSIS; BIOPSY; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR BASEMENT MEMBRANE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; OBESITY; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 55949133397     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.05.004     Document Type: Article

References (35)

1. Kimmelstiel P., and Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 12 (1936) 83-105
2. Mandelanakis N., Mendoza N., Pirani C., and Pollak V.E. Lobular glomerulonephritis and membranoproliferative glomerulonephritis. Medicine 50 (1971) 319-354
3. Gallo G.R., Feiner H.D., Katz L.A., and Feldmann G.M. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis. Am J Path 99 (1980) 621-644
4. Alpers C.E. Immunotactiod glomerulopathy. Am J Kidney Dis 20 (1992) 198-199
5. Alpers C.E. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. Two entities, not one. Am J Kidney Dis 22 (1993) 448-451
6. Fogo A., Qureshi N., and Horn R.G. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 22 (1993) 367-377
7. Nash D.A., Rogers P.W., and Langlinais P.C. Diabetic glomerulosclerosis without glucose intolerance. Am J Med 59 (1975) 191-199
8. Jensen R., and Larsen V.S. Nodular mesangial glomerulosclerosis in patients without manifest diabetes mellitus. Int Urol Nephrol 22 (1990) 95-103
9. Alpers C.E., and Biava C.G. Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): a distinct diagnostic entity. Clin Nephrol 32 (1989) 68-74
10. Herzenberg, Holden J.K., Singh S., and Magil A.B. Idiopathic nodular glomerulosclerosis. Am J Kidney Dis 34 (1999) 560-564
11. Muller-Hocker J., Weiss M., Thoenes G.H., Grund A., and Nerlich A. A case of idiopathic nodular glomerulosclerosis mimicking diabetic glomerulosclerosis (Kimmelstiel-Wilson type). Pathol Res Pract 198 (2002) 375-379
12. Markowitz G.S., Lin J., Valeri, Avila C., Nasr S.H., and D'Agati V.D. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol 33 (2002) 826-835
13. Sanai T., Okuda S., Yoshimitsu T., et al. Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus. Nephrology 12 (2007) 69-73
14. Kuppachi S., Idris N., Chander N.P., and Yoo J. Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker-case report and review of literature. Nephrology Dialysis Transplantation 21 (2006) 3571-3575
15. delman R. Obesity and renal disease. Curr Opin Nephrol Hypertens 11 (2002) 331-335
16. Henegar J., Bigler S., Henegar L., Tuagi S., and Hall J. Functional and structural changes in the kidney in the early stages of obesity. Am J Soc Nephrol 12 (2001) 1211-1217
17. Kambham N., Markowitz G., Valeri A., Lin J., and D'Agati V. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59 (2001) 1498-1509
18. Stenvinkel P. Leptin and its clinical implications in chronic renal failure. Miner Electrolyte Metab 25 (1999) 298-302
19. Villarreal D., Reams G., Freeman R.H., and Taraben A. Renal effects of leptin in normotensive, hypertensive and obese rats. Am J Physiol 275 (1998) 2056-2060
20. Wolf G., Chen S., Han D.C., and Ziyadeh F.N. Leptin and renal disease. Am J Kidney Dis 39 (2002) 1-11
21. Hauner H., Bender M., Haastert B., and Hube F. Plasma concentrations of soluble TNF-receptors in obese subjects. Int J Obes 22 (1998) 1239-1243
22. Kern P., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 (2001) E745-E751
23. Yudkin J., Stehouwer C., Emeis J., and Coppack S. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
24. Esposito K., Nappo F., Marfella R., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
25. Engeli S., Feldpausch M., Gorzelniak K., et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52 (2003) 942-947
26. Frayn K. Visceral fat and insulin resistance: causative or correlative?. Br J Nutr 83 (2000) S71-S77
27. Ferrannini E., Barrett E., Bevilacqua S., and DeFronzo R. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72 (1983) 1737-1747
28. Svedberg J., Bjorntorp P., and Lonnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39 (1990) 570-574
29. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults. JAMA 287 (2002) 356-359
30. Saito Y., Kida H., Takeda S., et al. Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions. Kidney Int 34 (1988) 389-396
31. Stout L.C., Kumar S., and Whorton E.B. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson nodule. Hum Pathol 24 (1993) 77-89
32. Min W., and Yamanaka N. Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virchows Arch A Pathol Anat Histopathol 423 (1993) 201-207
33. Kanesaki Y., Suzuki D., Uehara G., et al. Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis 45 (2005) 288-294
34. de Vriese A.S., Tilton R.G., Elger M., Stephan C.C., Kriz W., and Lameire N.H. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12 (2001) 993-1000
35. Flyvbjerg A., Dagnaes-Hansen F., De Vriese A.S., Schrijvers B.F., Tilton R.G., and Rasch R. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51 (2002) 3090-3094